Australian-American biotech Vaxxas has announced the completion of enrolment for its Phase I avian influenza A (H7N9) vaccine, which is delivered through a microneedle patch applied to the skin.

Some of the issues: In March 2017, an outbreak of highly pathogenic avian influenza (HPAI) H7N9 virus was detected in two commercial chicken breeder flocks in the United States. This North ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a ...

Avian flu, or HPAI, is a viral infection that primarily ... It also stated that bird flu strain H7N9 has caused outbreaks in China since 2013, leading to over 1,500 cases and a 40% fatality ...

Avian flu is not just for the birds; cases have been reported in the United States in dairy cows, as well as types of cats, a ...

“As oseltamivir is the most widely used therapeutic and prophylactic against IAV, the continued circulation of viruses ...

AIM ImmunoTech (AIM) announced that Paul Goepfert, MD, of the University of Alabama-Birmingham, has agreed to act as the Principal Investigator ...